Target Name: TAS2R16
NCBI ID: G50833
Review Report on TAS2R16 Target / Biomarker Content of Review Report on TAS2R16 Target / Biomarker
TAS2R16
Other Name(s): taste 2 receptor member 16 | OTTHUMP00000211449 | taste receptor, type 2, member 16 | T2R16 | Taste receptor type 2 member 16 | Candidate taste receptor T2R16 | Taste 2 receptor member 16 | T2R16_HUMAN | BGLPT | candidate taste receptor T2R16

TAS2R16: A Potential Drug Target and Biomarker for Taste Cell Communication

Taste is an essential modality of sensory input that plays a crucial role in our daily lives. The sense of taste is mediated by taste cells, which are located in the tongue and include taste buds made up of taste receptor proteins. TAS2R16, also known as TAS2R16R, is a G protein-coupled receptor (GPCR) that is expressed in taste cells and is involved in taste perception.

GPCR is a family of transmembrane proteins that play a broad range of roles in cellular signaling. They are involved in various physiological processes, including sensory perception, neurotransmitter signaling, and hormone signaling. GPCR receptors are involved in taste perception by transmitting signals from the taste cells to the brain.

TAS2R16 is a GPCR that is expressed in taste cells and is involved in taste perception. It is a 16-kDa protein that consists of an extracellular domain, a transmembrane domain, and an intracellular domain. The extracellular domain of TAS2R16 contains a N-terminal alpha-helices that are involved in protein-protein interactions and are thought to play a role in TAS2R16's localization to the taste cells.

The transmembrane domain of TAS2R16 contains a single transmembrane alpha-helix that is involved in the formation of the channel that allows taste cells to transmit signals to the brain. The intracellular domain of TAS2R16 contains a single GPCR-activating protein (GAP) domain that is involved in the regulation of taste perception.

TAS2R16 is involved in taste perception by transmitting signals from the taste cells to the brain. Taste cells contain taste receptor proteins that are involved in the detection of various taste cations, including sweet, sour, and bitter tastes. When a taste cell is stimulated by a taste cation, it sends a signal to the GPCR receptor through its transmembrane domain. The GPCR receptor is then activated by the GAP domain, which results in the formation of a taste neuron that carries the taste information to the brain.

TAS2R16 is a potential drug target for taste disorders. taste disorders can be caused by a variety of factors, including genetic, neurodegenerative, and metabolic disorders. TAS2R16 is thought to be involved in the regulation of taste perception, and targeting TAS2R16 may be a promising approach to treating taste disorders.

TAS2R16 is also a potential biomarker for taste disorders. Taste disorders can be detected by measuring the levels of certain genes that are involved in taste perception. By measuring the levels of TAS2R16, researchers can determine if taste disorders are present and identify potential drug targets.

In conclusion, TAS2R16 is a GPCR that is involved in taste perception and may be a potential drug target for taste disorders. The role of TAS2R16 in taste perception and its potential as a drug target make it an attractive target for further research.

Protein Name: Taste 2 Receptor Member 16

Functions: Gustducin-coupled receptor implicated in the perception of bitter compounds in the oral cavity and the gastrointestinal tract. Signals through PLCB2 and the calcium-regulated cation channel TRPM5

The "TAS2R16 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TAS2R16 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

TAS2R19 | TAS2R20 | TAS2R3 | TAS2R30 | TAS2R31 | TAS2R38 | TAS2R39 | TAS2R4 | TAS2R40 | TAS2R41 | TAS2R42 | TAS2R43 | TAS2R45 | TAS2R46 | TAS2R5 | TAS2R50 | TAS2R60 | TAS2R63P | TAS2R64P | TAS2R7 | TAS2R8 | TAS2R9 | TASL | TASOR | TASOR2 | TASP1 | Taste receptor type 2 | Taste Receptors Type 1 | TAT | TAT-AS1 | TATDN1 | TATDN2 | TATDN2P3 | TATDN3 | TAX1BP1 | TAX1BP3 | TBATA | TBC1D1 | TBC1D10A | TBC1D10B | TBC1D10C | TBC1D12 | TBC1D13 | TBC1D14 | TBC1D15 | TBC1D16 | TBC1D17 | TBC1D19 | TBC1D2 | TBC1D20 | TBC1D21 | TBC1D22A | TBC1D22A-AS1 | TBC1D22B | TBC1D23 | TBC1D24 | TBC1D25 | TBC1D26 | TBC1D27P | TBC1D28 | TBC1D29P | TBC1D2B | TBC1D3 | TBC1D30 | TBC1D31 | TBC1D32 | TBC1D3B | TBC1D3C | TBC1D3F | TBC1D3G | TBC1D3H | TBC1D3L | TBC1D3P1 | TBC1D3P2 | TBC1D4 | TBC1D5 | TBC1D7 | TBC1D8 | TBC1D8-AS1 | TBC1D8B | TBC1D9 | TBC1D9B | TBCA | TBCB | TBCC | TBCCD1 | TBCD | TBCE | TBCEL | TBCK | TBILA | TBK1 | TBKBP1 | TBL1X | TBL1XR1 | TBL1Y | TBL2 | TBL3 | TBP | TBPL1